Literature DB >> 15673210

Dexamethasone therapy in patients with brain tumors--a focus on tapering.

Ann E Nahaczewski1, Susan B Fowler, S Hariharan.   

Abstract

Administration of corticosteriods in brain tumor patients requires an understanding of the physiology of the adrenal system and desired patient response. Close attention to other concomitant medications will ensure adequate amounts of all drugs, including dexamethasone. Nurses need to assess patients' tolerance of dexamethasone, discuss these findings with physicians and pharmacists, and educate both patients and family members on doses and tapering schedules tailored to individual patient needs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15673210     DOI: 10.1097/01376517-200412000-00008

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  6 in total

1.  Exercise interest and preferences among patients diagnosed with primary brain cancer.

Authors:  Lee W Jones; Bebe Guill; Stephen T Keir; Karen Carter; Henry S Friedman; Darell D Bigner; David A Reardon
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

Review 2.  Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients.

Authors:  S Sideris; F Aoun; C N Martinez; S Latifyan; A Awada; G Costante; T Gil
Journal:  J Endocrinol Invest       Date:  2016-01-19       Impact factor: 4.256

3.  Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.

Authors:  Luciana Rosa; Leticia S Galant; Dhébora M Dall'Igna; Janaina Kolling; Cassiana Siebert; Patrícia F Schuck; Gustavo C Ferreira; Angela T S Wyse; Felipe Dal-Pizzol; Giselli Scaini; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2015-07-02       Impact factor: 5.590

4.  Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline.

Authors:  X Kostaras; F Cusano; G A Kline; W Roa; J Easaw
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

5.  Steroid management in newly diagnosed glioblastoma.

Authors:  Mariel B Deutsch; Katherine S Panageas; Andrew B Lassman; Lisa M Deangelis
Journal:  J Neurooncol       Date:  2013-03-06       Impact factor: 4.130

6.  A longitudinal, qualitative and quantitative exploration of daily life and need for rehabilitation among patients with high-grade gliomas and their caregivers.

Authors:  K Piil; M Jarden; J Jakobsen; K Bang Christensen; M Juhler
Journal:  BMJ Open       Date:  2013-07-11       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.